Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes

International Journal of Vascular Medicine

Volumn 2011, Issue , 2011, Pages

  Futrakul, Narisa ^a   Futrakul, Prasit ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054961684     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2011/971524     Document Type: Review

References (48)

1. Futrakul N., Sila-asna M., Futrakul P., Therapeutic strategy towards renal restoration in chronic kidney disease. Asian Biomedicine 2007 1 33 44
2. Futrakul N., Vongthavarawat V., Sirisalipotch S., Chairatanarat T., Futrakul P., Suwanwalaikorn S., Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes. Clinical Hemorheology and Microcirculation 2005 32 1 59 65 2-s2.0-12844286168
3. Futrakul P., Yenrudi S., Futrakul N., Sensirivatana R., Kingwatanakul P., Jungthirapanich J., Cherdkiadtikul T., Laohapaibul A., Watana D., Singkhwa V., Futrakul S., Pongsin P., Tubular function and tubulointerstitial disease. American Journal of Kidney Diseases 1999 33 5 886 891 2-s2.0-0032906710
4. Dimmelerf S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A. M., Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999 399 6736 601 605 2-s2.0-0033542476 10.1038/21224
5. Malek A. M., Izumo J., Molecular aspects of signal transduction of shear stress in the endothelial cell. Journal of Hypertension 1994 12 9 989 1000 2-s2.0-0028040352
6. Treins C., Giorgetti-Peraldi S., Murdaca J., Regulation of vascular endothelial growth factor expression by advanced glycation end products. Journal of Biological Chemistry 2001 276 47 43836 43841 2-s2.0-0035941358 10.1074/jbc.M106534200
7. Nakagawa T., Li J. H., Garcia G., Murdaca J., Van Obberghen E., TGF-beta induces proangiogenic and antiangiogenic factors via paralled but distinct Smad pathways. Kidney International 2004 66 605 618
8. Williams B., Baker A. Q., Gallacher B., Breitman M. L., Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 1995 25 5 913 917 2-s2.0-0029061789
9. Hohenstein B., Hausknecht B., Bochmer K., Riess R., Brekken R. A., Hugo C. P. M., Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney International 2006 69 9 1654 1661 2-s2.0-33646501496 10.1038/sj.ki.5000294
10. Liao J. K., Fine-tuning the angiogenic response to vascular endothelial growth factor. Circulation Research 2008 103 3 229 230 2-s2.0-53549108606 10.1161/CIRCRESAHA.108.181628
11. Miyauchi H., Minamino T., Tateno K., Kunieda T., Toko H., Komuro I., Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. The EMBO Journal 2004 23 1 212 220 2-s2.0-0842263745 10.1038/sj.emboj.7600045
12. Bussolati B., Dunk C., Grohman M., Kontos C. K., Mason J., Ahmed A., Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. American Journal of Pathology 2001 159 3 993 1008 2-s2.0-0034848647
13. Kolatsi-Joannou M., Lix Z., Suda T., Yuan H. T., Woolf A. S., Expression and potential role of angiopoietins and Tie-2 in early development of the mouse metanephros. Developmental Dynamics 2001 222 1 120 126 10.1002/dvdy.1170
14. Satchell S. C., Anderson K. L., Mathieson P. W., Angiopoietin-1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. Journal of the American Society of Nephrology 2004 15 3 566 574 2-s2.0-1542349097 10.1097/01.ASN.0000115397.22519.03
15. Natarajan R., Bai W., Lanting L., Gonzales N., Nadler J., Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. American Journal of Physiology 1997 273 5 H2224 H2231 2-s2.0-0030662097
16. Osterby R., Bangstad H. J., Nyberg G., Rudberg S., On glomerular structural alterations in type-1 diabetes: companions of early diabetic glomerulopathy. Virchows Archiv 2001 438 2 129 135 2-s2.0-0035111630 10.1007/s004280000311
17. Futrakul N., Butthep P., Futrakul P., Altered vascular homeostasis in type 2 diabetic nephropathy. Renal Failure 2009 31 3 207 210 2-s2.0-65549125457 10.1080/08860220802669859
18. Futrakul N., Butthep P., Futrakul P., Altered vascular homeostasis in chronic kidney disease. Clinical Hemorheology and Microcirculation 2008 38 3 201 207 2-s2.0-38749118294
19. Bortoloso E., Del Prete D., Vestra M. D., Gambaro G., Saller A., Antonucci F., Baggio B., Anglani F., Fioretto P., Quantitative and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. European Journal of Endocrinology 2004 150 6 799 807 2-s2.0-3242659972 10.1530/eje.0.1500799
20. Cooper M. E., Vranes D., Youssef S., Stacker S. A., Cox A. J., Rizkalla B., Casley D. J., Bach L. A., Kelly D. J., Gilbert R. E., Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 1999 48 11 2229 2239 2-s2.0-0032712434 10.2337/diabetes.48.11.2229
21. Kang D. H., Joly A. H., Oh S. W., Hugo C., Kerjaschki D., Gordon K. L., Mazzali M., Jefferson J. A., Hughes J., Madsen K. M., Schreiner G. F., Johnson R. J., Impaired angiogenesis in the remnant kidney model I. Potential role of vascular endothelial growth factor and thrombospondin-1. Journal of the American Society of Nephrology 2001 12 7 1434 1447 2-s2.0-0034922841
22. Yuan H. T., hyuan@ich.ucl.ac.uk Li X. Z., Pitera J. E., Long D. A., Woolf A. S., Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor- A and hypoxia-inducible factor-1 alpha. American Journal of Pathology 2003 163 6 2289 2301
23. Nishi J. I., Minamino T., Miyauchi H., Nojima A., Tateno K., Okada S., Orimo M., Moriya J., Fong G. H., Sunagawa K., Shibuya M., Komuro I., Vascular endothelial growth factor receptor-1 regulates postanatal angiogenesis through inhibition of the excessive activation of Akt. Circulation Research 2008 103 3 261 268 2-s2.0-53549123579 10.1161/CIRCRESAHA.108.174128
24. Loomans C. J., de Koning E. J., Staal F. J., Rookmaaker M. B., Verseyden C., de Boer H. C., Verhaar M. C., Braam B., Rabelink T. J., Van Zonneveld A. J., Endothelial progenitor cell dysfunction a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004 53 1 195 199 2-s2.0-9144271032 10.2337/diabetes.53.1.195
25. Tepper O. M., Galiano R. D., Capla J. M., Kalka C., Gagne P. J., Jacobowitz G. R., Levine J. P., Gurtner G. C., Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 106 22 2781 2786 2-s2.0-0037180517 10.1161/01.CIR.0000039526.42991.93
26. Rizkalla B., Forbes J. M., Cao Z., Boner G., Cooper M. E., Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. Journal of Hypertension 2005 23 1 153 164 2-s2.0-12344330373 10.1097/00004872-200501000-00026
27. Zhang C., Zhao Y. X., Zhang Y. H., Zhu L., Deng B. P., Zhou Z. L., Li S. Y., Lu X. T., Song L. L., Lei X. M., Tang W. B., Wang N., Pan C. M., Song H. D., Liu C. X., Dong B., dongbo1@medmail.com.cn Zhang Y., Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells. Proceedings of the National Academy of Sciences of the United States of America 2010 107 36 15886 15891 10.1073/pnas.1001253107
28. Yao D., Taguchi T., Matsumura T., Pestell R., Edelstein D., Giardino I., Suske G., Rabbani N., Thornalley P. J., Sarthy V. P., Hammes H. P., Brownlee M., High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. Journal of Biological Chemistry 2007 282 42 31038 31045 2-s2.0-35649026775 10.1074/jbc.M704703200
29. Yamamoto Y., Maeshima Y., Kitayama H., Kitamura S., Takazawa Y., Sugiyama H., Yamasaki Y., Makino H., Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 2004 53 7 1831 1840 2-s2.0-3042739353 10.2337/diabetes.53.7.1831
30. Woolf A. S., Gnudi L., Long D. A., Roles of angiopoietins in kidney development and disease. Journal of the American Society of Nephrology 2009 20 2 239 244 2-s2.0-59949085812 10.1681/ASN.2008020243
31. Lindenmeyer M. T., Kretzler M., Boucherot A., Berra S., Yasuda Y., Henger A., Eichinger F., Gaiser S., Schmid H., Rastaldi M. P., Schrier R. W., Schlöndorff D., Cohen C. D., Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. Journal of the American Society of Nephrology 2007 18 6 1765 1776 2-s2.0-34249901258 10.1681/ASN.2006121304
32. Sasso F. C., Torella D., Carbonara O., Ellison G. M., Torella M., Scardone M., Marra C., Nasti R., Marfella R., Cozzolino D., Indolfi C., Cotrufo M., Torella R., Salvatore T., Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. Journal of the American College of Cardiology 2005 46 5 827 834 2-s2.0-24044517938 10.1016/j.jacc.2005.06.007
33. Futrakul N., Kittikowit W., Yenrudi S., Reduced endothelial factor VIII staining in renal microcirculation correlates with hemodynamic alteration in nephrosis. Renal Failure 2003 25 5 759 764 2-s2.0-0141618432 10.1081/JDI-120024291
34. Li J., jinhua.li@med.monash.edu.au Bertram J. F., Review: endothelial-myofibroblast transition, a new player in diabetic renal fibrosis. Nephrology 2010 15 5 507 512 10.1111/j.1440-1797.2010.01319.x
35. Futrakul P., Sitprija V., Yenrudi S., Poshyachinda M., Sensirivatana R., Watana D., Singklwa V., Jungthirapanich J., Futrakul N., Glomerular endothelial dysfunction determines disease progression: a hypothesis. American Journal of Nephrology 1997 17 6 133 140 2-s2.0-0030716430
36. Osterby R., Nyberg G., New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy. Journal of Diabetic Complications 1987 1 4 122 127 2-s2.0-0023429720
37. Kanesaki Y., Suzuki D., Uehara G., Toyoda M., Katoh T., Sakai H., Watanabe T., Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. American Journal of Kidney Diseases 2005 45 2 288 294 2-s2.0-15944376565 10.1053/j.ajkd.2004.09.020
38. Min W., Yamanaka N., Three-dimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy. Virchows Archiv 1993 423 3 201 207 2-s2.0-0027379945
39. Nakagawa T., Kosugi T., Haneda M., Rivard C. J., Long D. A., Abnormal angiogenesis in diabetic nephropathy. Diabetes 2009 58 7 1471 1478 2-s2.0-67650236579 10.2337/db09-0119
40. Wehner H., Nelischer G., Morphometric investigations on intrarenal vessels of streptozotocin-diabetic rats. Virchows Archiv 1991 419 3 231 235 2-s2.0-0026095917
41. Walten Berger J., New horizons in diabetes therapy: the angiogenesis paradox in diabetes: description of the problem and presentation of a unifying hypothesis. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry 2007 7 1 87 93 2-s2.0-34247163481
42. Shalaby F., Rossant J., Yamaguchi T. P., Gertsenstein M., Wu X. F., Breitman M. L., Schuh A. C., Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 1995 376 6535 62 66 2-s2.0-0029006696
43. Fong G. H., Rossant J., Gertsenstein M., Breitman M. L., Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995 376 6535 66 70 2-s2.0-0029021660
44. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N. P., Risau W., Ullrich A., High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993 72 6 835 846 2-s2.0-0027466849 10.1016/0092-8674(93)90573-9
45. Scott McLeod D., Taomoto M., Cao J., Zhu Z., Witte L., Lutty G. A., Localizaiton of VEGF receptor 2 (KDR/flk1) and effects of blooding it in oxygen-induced retinapathy. Investigative Ophthalmology and Visual Science 2002 43 474 482
46. Futrakul N., Futrakul P., Vascular repair is adequately functional in early stage of diabetic nephropathy. Asian Biomedicine 2010 4 987 990
47. Ritt M., Ott C., Raff U., Schneider M. P., Schuster I., Hilgers K. F., Schlaich M. P., Schmieder R. E., Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. American Journal of Kidney Diseases 2009 53 2 281 289 2-s2.0-58249108732 10.1053/j.ajkd.2008.10.041
48. Futrakul N., Butthep P., Futrakul P., Sitprija V., Improvement of renal function in type 2 diabetic nephropathy. Renal Failure 2007 29 2 155 158 2-s2.0-33847202536 10.1080/08860220601095835